טאזוצין 2.25 גרם

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

PIPERACILLIN AS SODIUM 2 G/VIAL; TAZOBACTAM SODIUM 0.25 G/VIAL

Disponible depuis:

NEOPHARM LTD

Code ATC:

J01CR05

forme pharmaceutique:

POWDER FOR SOLUTION FOR INJECTION

Mode d'administration:

I.V

Fabriqué par:

WYETH PIPER. DIV.OF WYETH HOLDINGS CORP.

Groupe thérapeutique:

PIPERACILLIN AND ENZYME INHIBITOR

indications thérapeutiques:

Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Tazocin in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children above 2 years. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Date de l'autorisation:

2010-06-01